Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network
Status:
Suspended
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
National trial, multicenter, randomized, phase II comparing treatment intensification with
hepatic arterial infusion chemotherapy plus systemic chemotherapy (CT) to systemic
chemotherapy alone in patients with liver-only colorectal metastases (CRLM) considered still
non resectable after at least two months of systemic induction chemotherapy.